The KLK11 gene helps make an enzyme that cuts other proteins into smaller pieces, mainly in gland tissues such as the prostate. This controlled protein trimming supports normal cell signaling and the makeup of body fluids. If the gene does not work normally, these local processes may be altered, which can affect how nearby cells behave. Differences in KLK11 levels have also been studied in some cancers, so this gene sometimes comes up in cancer biomarker research.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Others mainly guide when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence your response to food, stress, and medicines. For a deeper look at this topic, more information is available in the LearnHub.
Overview
KLK11Gene function
What if the gene works
The KLK11 gene helps make an enzyme that breaks down other proteins in body fluids and tissues. It is active in tissues such as the prostate and may support normal fluid balance and cell signaling.
Risk
What if the gene does not work
Changes in the KLK11 gene can reduce or alter an enzyme that cuts other proteins. Milder variants may slightly change how it is made or works, while more severe variants can greatly lower or stop its activity.
Treatment
What does that mean for your treatment
No KLK11-specific treatment or management approach is currently established for people with a pathogenic or loss of function variant in the KLK11 gene. KLK11 is being studied mainly as a cancer biomarker, especially in prostate and ovarian cancer, rather than as a guide for choosing a specific drug.
Gene function
What if the gene works
Many cells release the KLK11 protein into nearby fluids, where it helps fine tune other proteins. This protein cutting activity supports routine upkeep on tissue surfaces and in gland secretions. Understanding how the KLK11 gene works can make it easier to see how cells keep their local environment in balance.
The KLK11 gene makes a protease (a protein-cutting enzyme) that is released outside cells. It trims selected proteins in nearby fluids and on tissue surfaces so they can be used, reshaped, or cleared in a controlled way.
By processing proteins around cells, KLK11 helps keep the local tissue environment balanced. This can shape how proteins interact with each other and how cells respond to signals in their surroundings.
Many tissues release KLK11 into gland secretions, where ongoing protein processing is part of normal function. This helps maintain the usual makeup and behavior of those body fluids.
What is a variant?
A genetic variant is a slight difference in the DNA sequence of a gene. These differences are common and help make up normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply reflect natural genetic variation. Sometimes, however, a variant changes how a gene functions to a greater extent and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In the KLK11 gene, variants can change the protein's shape, stability, processing, or release from the cell, and some affect the active site that lets it cut other proteins. This is how KLK11 gene variants affect protein function at a cellular level: milder variants may partly reduce activity or secretion, while more disruptive variants can cause misfolding, abnormal RNA splicing, truncation, or loss of enzyme activity. The effect depends on the exact change and where it sits in the gene.
How variants are linked to conditions
Right now, there are no well-established health conditions linked to KLK11 gene variants in the way seen for some other genes. Research has explored possible KLK11 gene variant associations, but these findings are not yet broadly confirmed for a specific diagnosis. If you carry a change in the KLK11 gene, your own test result is best interpreted with your doctor or genetic counselor.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread across the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, having a variant tied to a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-understood variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the KLK11 gene itself. If KLK11 appears on a genetic test, a doctor or genetic counselor can explain what that result may mean in the context of your personal and family history.
Inheritance of KLK11 variants
There is not yet a broadly confirmed, disease-specific Mendelian pattern for the inheritance of KLK11 gene variants. Current research on the inheritance of KLK11 gene variants is still developing, so this gene is not usually described as having a clearly established autosomal dominant, autosomal recessive, or X-linked condition. The KLK11 gene is located on chromosome 19, which is an autosome, so you inherit one copy from each parent.
What does my KLK11 result mean for my family?
There is not yet a broadly confirmed pattern showing that a KLK11 result causes a specific inherited condition in families. A KLK11 finding may have different meanings depending on why the test was done, so the family impact is often unclear without the full result and medical context.
Genetic information
Genetic testing
How you find out about variants
Variants in the KLK11 gene are found with genetic testing, usually from a blood sample, saliva, or cheek swab. A lab reads the gene's DNA sequence to look for changes and compares them with known patterns to judge whether a variant is likely benign or linked to health findings. KLK11 genetic testing is often part of a larger gene panel.
When should I consider getting a genetic test?
There is not yet a broadly established, KLK11-specific reason for genetic testing in routine care. Decisions about testing are usually based on your personal health history, family history, and the wider set of genes linked more clearly to an inherited condition.
A genetic result is only one part of your health story
Genetic test results can be informative, but what they tell you varies depending on the condition and the kind of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic findings can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds at its target, so the same treatment may work better for one person than for another. This kind of variation is common and can influence how much benefit a medicine gives or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It looks at gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the KLK11 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. If you have concerns about side effects, how well a treatment is working, or how medicines fit with your other health conditions, it is best to discuss them with your doctor or pharmacist.
History
KLK11 came into view during the late 1990s and early 2000s, when researchers were mapping the human kallikrein gene family on chromosome 19. It was identified alongside several closely related genes, at a time when new sequencing methods were rapidly expanding the catalog of human genes. Building on this early work, scientists gave it the name KLK11 as the numbering of the kallikrein family became more standardized. Early studies drew attention to its activity in tissues such as the prostate and other organs, which led to interest in its possible clinical relevance. Over time, descriptions became more precise as genetic databases and laboratory methods improved.